Middle East And Africa Neisseriaceae Infections Market By Type Of Bacteria (N. Meningitidis, N. Gonorrhoeae, N. Sicca N. Flava, N. Elongata, N. Cinerea, Others), By Disease (Gonorrhea, Septicemia, Meningitis, Sinusitis, Otitis, Pneumonia, CNS, Urinary, Respiratory Infections), By Antibacterial Drugs (B-lactum Antibiotics (Penicillin), Clavulanic Acid (Augmentin), Aminoglycosides (Streptomycin), Glycopeptides (Vancomycin), Polypeptides (Bacitracin), Rifamycins (Rifampicin), Chloramphenicol Tetracycline, Others), By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018–2023)

Middle East And Africa Neisseriaceae Infections Market By Type Of Bacteria (N. Meningitidis, N. Gonorrhoeae, N. Sicca N. Flava, N. Elongata, N. Cinerea, Others), By Disease (Gonorrhea, Septicemia, Meningitis, Sinusitis, Otitis, Pneumonia, CNS, Urinary, Respiratory Infections), By Antibacterial Drugs (B-lactum Antibiotics (Penicillin), Clavulanic Acid (Augmentin), Aminoglycosides (Streptomycin), Glycopeptides (Vancomycin), Polypeptides (Bacitracin), Rifamycins (Rifampicin), Chloramphenicol Tetracycline, Others), By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018–2023)

ID: 4510 | Pages: 131 | April 2018 | Region: Middle East and Africa


Middle East and Africa Neisseriaceae Infections market size was around USD XX billion in 2018. It is expected to grow at a CAGR of XX% to reach USD XX billion by 2023. Bacteria represent the essential class of micro-organisms that play a crucial role in the development of infection of any disease to human being and animal. They are classified into two types on the basis of gram staining test, viz., gram-positive bacteria and gram-negative bacteria. Neisseria is one of the most important class of bacteria which forms colonies on mucosal surfaces of animals. Neisseria comprises 11 species, out of which, two are pathogenic and others are harmless. These belong to gram negative class of bacteria, because these species show negative response to gram test.

As per the U.S. Centers for Disease Control and Prevention (CDC), more than 300,000 new cases of gonorrhea were reported in the U.S. in 2012, an enhancement of around 4% in contrast to 2011. Therefore, such rising prevalence of infections is an important growth driver of the market. Further, due to extensive R&D practices, number of drugs and formulations are on the way to enter in the market during the forecast period. Some of the important pipeline products include AXD0914, Cribrostatin-6, SM-295291 and SM-369926 amongst numerous others. In addition, owing to rising incidences of homosexuality and bisexuality, the threat of gonorrhea has also increased. These factors are aided by rising awareness regarding the infections and diseases and rising medical expenditure. Due to these, the market is anticipated to grow at steady rate.On the other hand, factors such as government austerity, high cost of treatment and R&D, and ignorance towards the symptoms may hamper the growth of the market to certain extent.

Middle East and Africa Neisseriaceae Infections market segmentation by various bacteria that belongs to the class and diseases associated with them, such as, Acinetobacter, Kingella, Neisseria, Moraxella and Oligella. Neisseria contains bacteria such as N. meningitidis, N. gonorrhoeae, N. sicca, N. flava, N. elongata, N. cinerea and others. Out of which, N. gonorrhoeae causes gonorrhea and N. meningitidis causes septicemia and meningitis. Moraxella catarrhalis causes otitis, sinusitis, and pneumonia in adults. Kingella kingae causes urinary, CNS, and respiratory infections. Furthermore, it is classified on the basis of antibacterial drugs, like, aminoglycosides (Streptomycin), B-lactum antibiotics (Penicillin), clavulanic acid (Augmentin), glycopeptides (Vancomycin), polypeptides (Bacitracin), rifamycins (Rifampicin), chloramphenicol, tetracycline and many others. Neisseriaceae Infections market geographical segmentation by Middle East and Africa.

Some of the major Neisseriaceae Infections market leaders are Aphios Corporation, Basilea Pharmaceuticals Ltd., Pfizer, Inc., GSK plc, AstraZeneca plc, Adenium Biotech ApS, Dainippon Sumitomo Pharma Co., Ltd., Theravance, Inc., and Pfizer, Inc. amongst many others.

1. Introduction                                                                 

                1.1 Market Definition                                                    

                1.2 Study Deliverables                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                          

                1.4 General Study Assumptions                                                

2. Research Methodology                                                                           

                2.1 Introduction                                                               

                2.2 Research Phases                                                      

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design                                                         

                2.4 Study Timeline                                                          

3. Overview                                                                       

                3.1 Executive Summary                                                

                3.2 Key Inferences                                                         

                3.3 Epidemology                                                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                    

                4.1 Market Drivers                                                          

                4.2 Market Restraints                                                    

                4.3 Key Challenges                                                         

                4.4 Current Opportunities in the Market                                                              

5. Market Segmentation                                                                              

                5.1 Type Of Bacteria                                                       

                                5.1.1 Introduction                                           

                                5.1.2 N. Meningitidis                                      

                                5.1.3 N. Gonorrhoeae                                   

                                5.1.4 N. Sicca                                     

                                5.1.5 N. Flava                                    

                                5.1.6 N. Elongata                                             

                                5.1.7 N. Cinerea                                               

                                5.1.8 Others                                      

                                5.1.9  Y-o-Y Growth Analysis, By Type Of Bacteria                                             

                                5.1.10  Market Attractiveness Analysis, By Type Of Bacteria                                         

                                5.1.11  Market Share Analysis, By Type Of Bacteria                                          

                5.2 Disease                                                        

                                5.2.1 Introduction                                           

                                5.2.2 Gonorrhea                                              

                                5.2.3 Septicemia                                              

                                5.2.4 Meningitis                                               

                                5.2.5 Sinusitis                                    

                                5.2.6 Otitis                                          

                                5.2.7 Pneumonia                                             

                                5.2.8 CNS                                            

                                5.2.9 Urinary                                     

                                5.2.10 Respiratory Infections                                     

                                5.2.11 Y-o-Y Growth Analysis, By Disease                                             

                                5.2.12 Market Attractiveness Analysis, By Disease                                           

                                5.2.13 Market Share Analysis, By Disease                                             

                5.3 Antibacterial Drugs                                                  

                                5.3.1 Introduction                                           

                                5.3.2 B-lactum Antibiotics (Penicillin)                                      

                                5.3.3 Clavulanic Acid (Augmentin)                                            

                                5.3.4 Aminoglycosides (Streptomycin)                                   

                                5.3.5 Glycopeptides (Vancomycin)                                          

                                5.3.6 Polypeptides (Bacitracin)                                  

                                5.3.7 Rifamycins (Rifampicin)                                     

                                5.3.8 Chloramphenicol                                  

                                5.3.9 Tetracycline                                            

                                5.3.10 Others                                    

                                5.3.11 Y-o-Y Growth Analysis, By Antibacterial Drugs                                       

                                5.3.12  Market Attractiveness Analysis, By Antibacterial Drugs                                    

                                5.3.13  Market Share Analysis, By Antibacterial Drugs                                     

6. Geographical Analysis                                                                              

                6.1 Introduction                                                               

                                6.1.1 Regional Trends                                    

                                6.1.2 Impact Analysis                                     

                                6.1.3 Y-o-Y Growth Analysis                                        

                                                6.1.3.1 By Geographical Area                     

                                                6.1.3.2 By Type Of Bacteria                         

                                                6.1.3.3 By Disease                           

                                                6.1.3.4 By Antibacterial Drugs                    

                                6.1.4  Market Attractiveness Analysis                                     

                                                6.1.4.1 By Geographical Area                     

                                                6.1.4.2 By Type Of Bacteria                         

                                                6.1.4.3 By Disease                           

                                                6.1.4.4 By Antibacterial Drugs                    

                                6.1.5  Market Share Analysis                                      

                                                6.1.5.1 By Geographical Area                     

                                                6.1.5.2 By Type Of Bacteria                         

                                                6.1.5.3 By Disease                           

                                                6.1.5.4 By Antibacterial Drugs                    

                6.2 Middle-East                                                                

                6.3 Africa                                                            

7. Strategic Analysis                                                                       

                7.1 PESTLE analysis                                                         

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis                                                              

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

8. Market Leaders' Analysis                                                                        

                8.1 Basilea Pharmaceuticals Ltd.                                               

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Financial analysis                                  

                                8.1.4 Recent Developments                                       

                                8.1.5 SWOT analysis                                       

                                8.1.6 Analyst View                                          

                8.2 AstraZeneca plc                                                        

                8.3 Adenium Biotech ApS                                                            

                8.4 Dainippon Sumitomo Pharma Co. Ltd.                                                            

                8.5 Aphios Corporation                                                 

                8.6 Pfizer Inc.                                                    

                8.7 GSK plc                                                         

                8.8 Theravance Inc.                                                        

9. Competitive Landscape                                                                           

                9.1 Market share analysis                                                            

                9.2 Merger and Acquisition Analysis                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                         

                9.4 New Product Launches                                                         

10. Market Outlook and Investment Opportunities                                                                         

Appendix                                                                           

                a) List of Tables                                                

                b) List of Figures                                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of type, Disease, Antibacterial Drugs along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the Middle East and Africa Market; which includes broadly demographic, economic and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Middle East and Africa Neisseriaceae Infections Market By Type Of Bacteria, From 2018-2023 ( USD Million )
  2. Middle East and Africa N. Meningitidis Market By Region, From 2018-2023 ( USD Million )
  3. Middle East and Africa N. Gonorrhoeae Market By Region, From 2018-2023 ( USD Million )
  4. Middle East and Africa N. Sicca Market By Region, From 2018-2023 ( USD Million )
  5. Middle East and Africa N. Flava Market By Region, From 2018-2023 ( USD Million )
  6. Middle East and Africa N. Elongata Market By Region, From 2018-2023 ( USD Million )
  7. Middle East and Africa N. Cinerea Market By Region, From 2018-2023 ( USD Million )
  8. Middle East and Africa Others Market By Region, From 2018-2023 ( USD Million )
  9. Middle East and Africa Neisseriaceae Infections Market By Disease, From 2018-2023 ( USD Million )
  10. Middle East and Africa Gonorrhea Market By Region, From 2018-2023 ( USD Million )
  11. Middle East and Africa Septicemia Market By Region, From 2018-2023 ( USD Million )
  12. Middle East and Africa Meningitis Market By Region, From 2018-2023 ( USD Million )
  13. Middle East and Africa Sinusitis Market By Region, From 2018-2023 ( USD Million )
  14. Middle East and Africa Otitis Market By Region, From 2018-2023 ( USD Million )
  15. Middle East and Africa Pneumonia Market By Region, From 2018-2023 ( USD Million )
  16. Middle East and Africa CNS Market By Region, From 2018-2023 ( USD Million )
  17. Middle East and Africa Urinary Market By Region, From 2018-2023 ( USD Million )
  18. Middle East and Africa Respiratory Infections Market By Region, From 2018-2023 ( USD Million )
  19. Middle East and Africa Neisseriaceae Infections Market By Antibacterial Drugs, From 2018-2023 ( USD Million )
  20. Middle East and Africa B-lactum Antibiotics (Penicillin) Market By Region, From 2018-2023 ( USD Million )
  21. Middle East and Africa Clavulanic Acid (Augmentin) Market By Region, From 2018-2023 ( USD Million )
  22. Middle East and Africa Aminoglycosides (Streptomycin) Market By Region, From 2018-2023 ( USD Million )
  23. Middle East and Africa Glycopeptides (Vancomycin) Market By Region, From 2018-2023 ( USD Million )
  24. Middle East and Africa Polypeptides (Bacitracin) Market By Region, From 2018-2023 ( USD Million )
  25. Middle East and Africa Rifamycins (Rifampicin) Market By Region, From 2018-2023 ( USD Million )
  26. Middle East and Africa chloramphenicol, Market By Region, From 2018-2023 ( USD Million )
  27. Middle East and Africa tetracycline Market By Region, From 2018-2023 ( USD Million )
  28. Middle East and Africa Others Market By Region, From 2018-2023 ( USD Million )
  29. Middle East Neisseriaceae Infections Market By Type Of Bacteria, From 2018-2023 ( USD Million )
  30. Middle East Neisseriaceae Infections Market By Disease, From 2018-2023 ( USD Million )
  31. Middle East Neisseriaceae Infections Market By Antibacterial Drugs, From 2018-2023 ( USD Million )
  32. Africa Neisseriaceae Infections Market By Type Of Bacteria, From 2018-2023 ( USD Million )
  33. Africa Neisseriaceae Infections Market By Disease, From 2018-2023 ( USD Million )
  34. Africa Neisseriaceae Infections Market By Antibacterial Drugs, From 2018-2023 ( USD Million )
Middle East and Africa Microbial Identification Market by Method (Genotypic, Proteomics-based, Phenotypic), Application (F&B, Diagnostic, Pharmaceutical, Environmental), Product (Identification Services, Consumables...
Latin America Microbial Identification Market By Method (Genotypic, Proteomics-based, Phenotypic), Application (F&B, Diagnostic, Pharmaceutical, Environmental), Product (Identification Services, Consumables, Instrum...
Asia-Pacific Microbial Identification Market By Method (Genotypic, Proteomics-based, Phenotypic), Application (F&B, Diagnostic, Pharmaceutical, Environmental), Product (Identification Services, Consumables, Instrume...
Europe Microbial Identification Market By Method (Genotypic, Proteomics-based, Phenotypic), Application (F&B, Diagnostic, Pharmaceutical, Environmental), Product (Identification Services, Consumables, Instruments), ...
North America Microbial Identification Market by Method (Genotypic, Proteomics-based, Phenotypic), Application (F&B, Diagnostic, Pharmaceutical, Environmental), Product (Identification Services, Consumables, Instrum...
Microbial Identification Market by Method (Genotypic, Proteomics-based, Phenotypic), Application (F&B, Diagnostic, Pharmaceutical, Environmental), Product (Identification Services, Consumables, Instruments), End Use...
Middle East & Africa Cell Harvesting Systems Market by Application (Bone Marrow, Umbilical Cord, Adipose Tissue, Peripheral Blood), by End-user (Academic Institutes, Hospitals, Diagnostic Labs, Research Centres), by...
Latin America Cell Harvesting Systems Market by Application (Bone Marrow, Umbilical Cord, Adipose Tissue, Peripheral Blood), by End-user (Academic Institutes, Hospitals, Diagnostic Labs, Research Centres), by Techni...
Asia Pacific Cell Harvesting Systems Market by Application (Bone Marrow, Umbilical Cord, Adipose Tissue, Peripheral Blood), by End-user (Academic Institutes, Hospitals, Diagnostic Labs, Research Centres), by Techniq...
Europe Cell Harvesting Systems Market By Application (Bone Marrow, Umbilical Cord, Adipose Tissue, Peripheral Blood), By End-user (Academic Institutes, Hospitals, Diagnostic Labs, Research Centers), By Techniques (B...
North America Cell Harvesting Systems Market by Application (Bone Marrow, Umbilical Cord, Adipose Tissue, Peripheral Blood), by End-user (Academic Institutes, Hospitals, Diagnostic Labs, Research Centres), by Techni...
Cell Harvesting Systems Market by Application (Bone Marrow, Umbilical Cord, Adipose Tissue, Peripheral Blood), by End-user (Academic Institutes, Hospitals, Diagnostic Labs, Research Centres), by Techniques (Blastome...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.